We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $133B
1-Year Est. Return 43.5%
This Fund
S&P 500
This Quarter Est. Return
+14.19%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$117B
AUM Growth
+$9.87B
Cap. Flow
-$1.11B
Cap. Flow %
-0.95%
Top 10 Hldgs %
30.52%
Holding
4,391
New
216
Increased
2,182
Reduced
1,536
Closed
202

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$89.2M
2
FLUT icon
Flutter Entertainment
FLUT
+$43.9M
3
OKTA icon
Okta
OKTA
+$32.1M
4
CHWY icon
Chewy
CHWY
+$31.8M
5
COIN icon
Coinbase
COIN
+$26.9M

Sector Composition

Rank Sector Weight
1 Technology 31.83%
2 Financials 13.86%
3 Consumer Discretionary 10.9%
4 Healthcare 9.41%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEB icon
1551
Pebblebrook Hotel Trust
PEB
$2.11B
$3.82M ﹤0.01%
381,981
+5,280
+1% +$49.1K
TPC
1552
Tutor Perini Cor
TPC
$4.41B
$3.81M ﹤0.01%
81,505
+2,783
+4% +$88.6K
NTB icon
1553
Bank of N.T. Butterfield & Son
NTB
$2.31B
$3.81M ﹤0.01%
86,093
+3,820
+5% +$156K
ATKR icon
1554
Atkore
ATKR
$3.19B
$3.81M ﹤0.01%
53,992
+1,136
+2% +$73.7K
SCL icon
1555
Stepan Co
SCL
$1.45B
$3.81M ﹤0.01%
69,738
+3,965
+6% +$209K
ALIT icon
1556
Alight
ALIT
$261M
$3.79M ﹤0.01%
33,488
+1,528
+5% +$164K
DAVE icon
1557
Dave Inc
DAVE
$4.09B
$3.78M ﹤0.01%
14,081
+2,954
+27% +$466K
NVEE
1558
DELISTED
NV5 Global
NVEE
$3.77M ﹤0.01%
163,357
+6,101
+4% +$122K
RARE icon
1559
Ultragenyx Pharmaceutical
RARE
$1.42B
$3.77M ﹤0.01%
103,626
-1,167
-1% -$42.1K
HRMY icon
1560
Harmony Biosciences
HRMY
$2.33B
$3.77M ﹤0.01%
119,201
+10,128
+9% +$326K
INVA icon
1561
Innoviva
INVA
$1.53B
$3.74M ﹤0.01%
186,084
+7,954
+4% +$153K
VRE
1562
DELISTED
Veris Residential
VRE
$3.73M ﹤0.01%
250,742
-6,169
-2% -$94.9K
LMND icon
1563
Lemonade
LMND
$3.4B
$3.73M ﹤0.01%
85,220
+7,514
+10% +$250K
DGII icon
1564
Digi International
DGII
$2.97B
$3.73M ﹤0.01%
107,050
+3,722
+4% +$114K
ROG icon
1565
Rogers Corp
ROG
$2.44B
$3.73M ﹤0.01%
54,450
+858
+2% +$55.3K
MXL icon
1566
MaxLinear
MXL
$8.16B
$3.71M ﹤0.01%
260,929
+37,550
+17% +$433K
SAH icon
1567
Sonic Automotive
SAH
$1.97B
$3.69M ﹤0.01%
46,223
+813
+2% +$54.7K
GFS icon
1568
GlobalFoundries
GFS
$26.6B
$3.69M ﹤0.01%
96,677
+6,451
+7% +$234K
TNET icon
1569
TriNet
TNET
$2.91B
$3.69M ﹤0.01%
50,483
+2,158
+4% +$171K
MNDY icon
1570
monday.com
MNDY
$3.34B
$3.69M ﹤0.01%
11,734
+502
+4% +$140K
LEG
1571
DELISTED
Leggett & Platt
LEG
$3.67M ﹤0.01%
411,745
+95,086
+30% +$819K
NNI icon
1572
Nelnet
NNI
$4.44B
$3.67M ﹤0.01%
30,279
+1,352
+5% +$151K
TWST icon
1573
Twist Bioscience
TWST
$11.9B
$3.66M ﹤0.01%
99,361
+3,397
+4% +$117K
BEPC icon
1574
Brookfield Renewable
BEPC
$5.19B
$3.65M ﹤0.01%
111,226
-12,390
-10% -$362K
AMR icon
1575
Alpha Metallurgical Resources
AMR
$2.23B
$3.64M ﹤0.01%
32,398
+2,333
+8% +$273K

Similar funds

RhumbLine Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, RhumbLine Advisers held 4,391 positions worth $117B, up 9.2% from $107B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

RhumbLine Advisers's Q2 2025 filing shows 216 new, 2,182 increased, 1,536 reduced and 202 closed positions. Its largest new stake was Ralliant Corp: 320,982 shares worth $15.6M. The largest sale was Discover Financial Services, an estimated $91M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q2 2025 buy was Ralliant Corp: 320,982 shares worth $15.6M.
  • RhumbLine Advisers added most to Capital One in Q2 2025, an estimated $89.2M increase.
  • RhumbLine Advisers's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $75.5M.
  • RhumbLine Advisers fully exited Discover Financial Services in Q2 2025, selling an estimated $91M.
  • RhumbLine Advisers's ten largest holdings make up 31% of its $117B portfolio in Q2 2025.
  • RhumbLine Advisers opened 216 new positions and closed 202 in Q2 2025.
  • RhumbLine Advisers's portfolio value rose 9.2% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.